Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

UB researchers have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.

Despite decades of experience, advanced health systems, and deep medical knowledge, the WHO European region is still at risk from the global epidemic of tuberculosis. There are at least three pressing ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

TB disease affects Asian persons more than others.‎ In 2023, TB disease was reported among 2,887 non-Hispanic Asian persons in the United States. This accounts for 30.0% of all people reported with TB ...